IXHL
Income statement / Annual
Last year (2024), Incannex Healthcare Limited's total revenue was $12,000.00,
and the percentage change from the previous year is not available.
In 2024, Incannex Healthcare Limited's net income was -$18.46 M.
See Incannex Healthcare Limited,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$12,000.00
|
$0.00
|
$540,170.00
|
$1.42 M
|
$417,449.00
|
$1,090.28
|
$749,191.00
|
$216,774.00
|
$68,304.00
|
$0.00
|
Cost of Revenue |
$0.00 |
$0.00 |
$4,375.86 |
$683,839.00 |
$310,797.00 |
$0.00 |
$387,890.00 |
$396,971.00 |
$48,924.00 |
$13,759.00 |
Gross Profit |
$12,000.00 |
$0.00 |
$535,794.00 |
$739,074.00 |
$106,652.00 |
$1,090.28 |
$361,301.00 |
-$180,197.00 |
$19,380.00 |
-$13,759.00 |
Gross Profit Ratio |
1 |
0 |
0.99 |
0.52 |
0.26 |
1 |
0.48 |
-0.83 |
0.28 |
0 |
Research and Development
Expenses |
$12.88 M
|
$41.66 M
|
$3.71 M
|
$3.54 M
|
$1.46 M
|
$516,807.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$16.83 M
|
$7.93 M
|
$193,985.00
|
$74,305.00
|
$315,854.00
|
$231,801.00
|
$573,429.00
|
$612,044.00
|
$268,893.00
|
$0.00
|
Selling & Marketing
Expenses |
$348,000.00
|
$84,000.00
|
$1.90 M
|
$3.26 M
|
$280,348.00
|
$66,564.00
|
$901,404.00
|
$423,035.00
|
$53,447.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$17.17 M
|
$8.01 M
|
$4.66 M
|
$4.84 M
|
$1.35 M
|
$375,150.00
|
$2.58 M
|
$1.85 M
|
$509,604.00
|
$486,807.00
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$30.05 M |
$49.67 M |
$8.37 M |
$8.40 M |
$2.81 M |
$891,957.00 |
$2.58 M |
$1.85 M |
$509,604.00 |
$486,807.00 |
Cost And Expenses |
$30.05 M |
$49.67 M |
$8.38 M |
$9.09 M |
$3.12 M |
$891,957.00 |
$2.97 M |
$2.24 M |
$558,528.00 |
-$500,567.00 |
Interest Income |
$206,000.00 |
$244,013.00 |
$4,547.67 |
$1,998.39 |
$3,046.85 |
$1,114.12 |
$2,364.06 |
$6,526.57 |
$424.25 |
$3,180.83 |
Interest Expense |
$0.00 |
$3,013.00 |
$218.07 |
-$10.46 |
-$89.80 |
$60,834.00 |
$9,983.04 |
$37,558.00 |
$89.76 |
$99,835.00 |
Depreciation &
Amortization |
$103,000.00
|
$23,000.00
|
$7.84 M
|
$7.64 M
|
$28,907.00
|
$29,954.00
|
$42,327.00
|
$23,270.00
|
$11,927.00
|
$13,759.00
|
EBITDA |
-$18.50 M
|
-$13.62 M
|
$0.00
|
$0.00
|
-$2.59 M
|
-$861,461.00
|
-$2.22 M
|
-$2.03 M
|
-$490,224.00
|
-$2.09 M
|
EBITDA Ratio |
-1542 |
0 |
0 |
0 |
-6.19 |
-790.13 |
-2.96 |
-9.35 |
-7.18 |
0 |
Operating Income Ratio
|
-2503.42
|
0
|
-14.51
|
-5.39
|
-6.47
|
-817.1
|
-2.96
|
-9.35
|
-7.18
|
0
|
Total Other
Income/Expenses Net |
$11.61 M
|
$857,000.00
|
-$2.45 M
|
-$863,451.00
|
-$12,418.00
|
-$110,395.28
|
-$160,173.00
|
-$14.11 M
|
-$59,592.45
|
-$1.70 M
|
Income Before Tax |
-$18.43 M |
-$48.81 M |
-$10.29 M |
-$8.53 M |
-$2.71 M |
-$1.00 M |
-$2.38 M |
-$16.14 M |
-$549,817.00 |
-$2.20 M |
Income Before Tax Ratio
|
-1535.75
|
0
|
-19.05
|
-5.99
|
-6.5
|
-918.35
|
-3.17
|
-74.44
|
-8.05
|
0
|
Income Tax Expense |
$30,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$203,999.00 |
-$229,796.00 |
$0.00 |
-$88,063.00 |
Net Income |
-$18.46 M |
-$48.81 M |
-$10.29 M |
-$8.53 M |
-$3.24 M |
-$1.91 M |
-$2.18 M |
-$15.90 M |
-$549,817.00 |
-$2.11 M |
Net Income Ratio |
-1538.25 |
0 |
-19.05 |
-5.99 |
-7.77 |
-1750.42 |
-2.91 |
-73.36 |
-8.05 |
0 |
EPS |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
EPS Diluted |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
-0.17 |
Weighted Average Shares
Out |
$16.16 M
|
$15.38 M
|
$297.79 M
|
$244.23 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
Weighted Average Shares
Out Diluted |
$16.16 M
|
$15.38 M
|
$297.79 M
|
$244.23 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
$12.11 M
|
Link |
|
|
|
|
|
|
|
|
|
|